Predicting the clinical status of human breast cancer by using gene expression profiles
暂无分享,去创建一个
R. Spang | M. West | C. Blanchette | H. Dressman | E. Huang | Seiichi Ishida | H. Zuzan | J. Olson | J. Marks | J. Nevins | J. Marks | Erich Huang
[1] B. V. Pedersen,et al. Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer , 1985, The British journal of surgery.
[2] P. Chambon,et al. Structure of the human oestrogen-responsive gene pS2. , 1987, Nucleic acids research.
[3] W. Godolphin,et al. Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. , 1988, Cancer research.
[4] P. Chambon,et al. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[5] W. McGuire,et al. HER-2/neu oncogene protein and prognosis in breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Benveniste,et al. Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis. , 1989, Journal of the National Cancer Institute.
[7] W. McGuire,et al. Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. , 1992, Journal of the National Cancer Institute.
[8] S. Steinberg,et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] M. Hendrix,et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.
[10] D. Berry,et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. , 1994, The New England journal of medicine.
[11] David B. Dunson,et al. Bayesian Data Analysis , 2010 .
[12] K. Cowan,et al. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] H. Rochefort. Oestrogen- and anti-oestrogen-regulated genes in human breast cancer. , 1995, Ciba Foundation symposium.
[14] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[15] S. Im,et al. Augmentation of tumor metastasis by platelet-activating factor. , 1996, Cancer research.
[16] C. Green,et al. Insulin/IGF-1 modulation of the expression of two estrogen-induced genes in MCF-7 cells , 1996, Molecular and Cellular Endocrinology.
[17] M. Hendrix,et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Matsuno,et al. Modulation of Protein Kinases and Microtubule-associated Proteins and Changes in Ultrastructure in Female Rat Pituitary Cells: Effects of Estrogen and Bromocriptine , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[19] F. May,et al. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells , 1997, The Journal of pathology.
[20] D. Ciocca,et al. Serological detection of heat shock protein hsp27 in normal and breast cancer patients. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[21] Rakesh Kumar,et al. Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells* * This work was supported by Grants NIH-RO-1-65622-04 (to R.J.S.), HD-25719 (to M.A.S.), GM-55985 and CA-44579 (to T.P.B.), and CA-65746 (to R.K.). , 1998, Endocrinology.
[22] R. Kumar,et al. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. , 1998, Endocrinology.
[23] R. Weigel,et al. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype. , 1998, Surgery.
[24] G. Löffler,et al. Induction of aromatase activity in human adipose tissue stromal cells by extracellular nucleotides--evidence for P2-purinoceptors in adipose tissue. , 1998, European journal of biochemistry.
[25] T. Gillman,et al. EVIDENCE FOR THE PRESENCE OF BOTH P1 AND P2 PURINOCEPTORS IN THE RAT MYOMETRIUM , 1998, Clinical and experimental pharmacology & physiology.
[26] M. Bittner,et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.
[27] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[28] R. Weigel,et al. GATA‐3 is expressed in association with estrogen receptor in breast cancer , 1999, International journal of cancer.
[29] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. Brown,et al. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. , 1999, Nucleic acids research.
[31] Christian A. Rees,et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Ni,et al. Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[33] H. Cody,et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. , 1999, Annals of surgery.
[34] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[35] Jim Albert,et al. Ordinal Data Modeling , 2000 .
[36] D. Botstein,et al. Singular value decomposition for genome-wide expression data processing and modeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. White,et al. Interaction in Vivo and in Vitro of the Metastasis-inducing S100 Protein, S100A4 (p9Ka) with S100A1* , 2000, The Journal of Biological Chemistry.
[38] F. Bertucci,et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes. , 2000, Human molecular genetics.
[39] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[40] S. Barsky,et al. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. , 2000, Cancer letters.
[41] Mike West,et al. Bayesian Regression Analysis in the "Large p, Small n" Paradigm with Application in DNA Microarray S , 2000 .
[42] D. Robyr,et al. Determinants of vitellogenin B1 promoter architecture. HNF3 and estrogen responsive transcription within chromatin. , 2000, The Journal of biological chemistry.
[43] L. Garcia-Segura,et al. Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats. , 2000, Journal of neurobiology.
[44] R. S. Richmond,et al. Functional estrogen receptors in adult articular cartilage: estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2. , 2000, Arthritis and rheumatism.
[45] P. Schneider,et al. Sentinel node biopsy in breast cancer. , 2000, Annals of surgery.
[46] P. Furth,et al. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice , 2000, Oncogene.
[47] L. Pinsky,et al. Interactions between androgen and estrogen receptors and the effects on their transactivational properties , 2000, Molecular and Cellular Endocrinology.
[48] M J O'Hare,et al. Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.
[49] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[50] T. Voeltzel,et al. Relationships of the Antiproliferative Proteins BTG1 and BTG2 with CAF1, the Human Homolog of a Component of the Yeast CCR4 Transcriptional Complex , 2001, The Journal of Biological Chemistry.